Tiansheng Pharmaceutical Group Co

Tiansheng Pharmaceutical Group Co Tangible Book Value per Share

The Tangible Book Value per Share of Tiansheng Pharmaceutical Group Co (002872.SZ) as of Oct 22, 2026 is 6.14 CNY. In the previous year, Tangible Book Value per Share was 5.41 CNY — a change of 13.45% (higher).

Tangible Book Value per Share

6.14CNY

YoY

13.45%

Last updated:

Tangible Book Value per Share of Tiansheng Pharmaceutical Group Co is 2025 6.14 CNY. Tangible Book Value per Share of Tiansheng Pharmaceutical Group Co was 2024 5.41 CNY. It decreases by 13.45% higher compared to the previous year.

The Tiansheng Pharmaceutical Group Co Tangible Book Value per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Tangible Book Value per Share
Date
Tangible Book Value per Share
Jan 1, 2018
8.37 CNY
Jan 1, 2019
7.74 CNY
Jan 1, 2020
6.19 CNY
Jan 1, 2021
6.12 CNY
Jan 1, 2022
5.86 CNY
Jan 1, 2023
5.60 CNY
Jan 1, 2024
5.41 CNY
Jan 1, 2025
6.14 CNY
The Tiansheng Pharmaceutical Group Co Tangible Book Value per Share history
YEARTangible Book Value per ShareYoY
6.14CNY+13.45%
5.41CNY-3.37%
5.60CNY-4.49%
5.86CNY-4.27%
6.12CNY-1.10%
6.19CNY-20.02%
7.74CNY-7.51%
8.37CNY-0.65%
8.42CNY+90.29%
4.43CNY+16.45%
3.80CNY+12.03%
3.39CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Tiansheng Pharmaceutical Group Co Stock analysis

What does Tiansheng Pharmaceutical Group Co do? Tiansheng Pharmaceutical Group Co., Ltd. generates revenue through the manufacturing and distribution of pharmaceutical products primarily within the domestic market. Its main products include pediatric lung cough particles, erythromycin enteric-coated capsules, silver ginseng Tongluo capsules, Salvia granules, Shugan Yi spleen granules, compound Ganoderma lucidum granules, Xiangdan injection, Qi and Diabetes tablets, liver capsule, Ling Jing capsule, lungs of nuclear paste, and Shen Qi Yi lung pill. The company focuses on domestic sales, targeting consumers seeking traditional Chinese medicine solutions for respiratory and digestive health. The firm's product portfolio emphasizes traditional Chinese medicine formulations, with specific offerings like Shugan Yi spleen granules for digestive issues and Ling Jing capsule for respiratory conditions. These products are distributed through domestic channels, catering to a market segment that prefers herbal remedies over conventional pharmaceuticals. Tiansheng's revenue stream is derived from the sale of these branded pharmaceutical items to pharmacies and healthcare providers within China. Tiansheng Pharmaceutical Group Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Tiansheng Pharmaceutical Group Co stock

Tangible Book Value per Share of Tiansheng Pharmaceutical Group Co is 6.14 CNY in 2025.

Tangible Book Value per Share of Tiansheng Pharmaceutical Group Co changed from 5.41 CNY to 6.14 CNY, representing a 13.45% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Tangible Book Value per Share Tiansheng Pharmaceutical Group Co since 2006 – with annual values, charts, and detailed analysis.

Tangible book value per share excludes intangible assets and goodwill, providing a more conservative measure of per-share net asset value.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Tiansheng Pharmaceutical Group Co

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Tiansheng Pharmaceutical Group Co